Tvardi Therapeutics, Inc. (TVRD)
Healthcare
Biotechnology
2.10 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -5.7 | -30 | -12 | -14 | -4.0 | -7.7 | -8.9 | -4.3 | -5.7 | -5.9 | -25 | |
| 0.5 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | 0.1 | 3.3 | -3.2 | 0.1 | 0.1 | 0.1 | -0.7 | 0.3 | 0.4 | 0.4 | 0.3 | |
| 4.6 | -1.5 | -4.9 | 2.1 | -11 | -1.8 | -3.7 | 2.4 | 0.9 | 1.2 | 0.4 | 4.9 | |
| 0.3 | 2.1 | 0.8 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 23 | -30 | 26 | 15 | 2.5 | 5.0 | -11 | -20 | 5.3 | 5.0 | 5.0 | -5.1 | |
| 1.1 | 36 | -0.7 | -0.6 | -0.7 | -1.6 | -1.6 | 22 | -0.3 | 0.0 | 0.0 | 22 | |
| 4.6 | -5.7 | -5.2 | 2.2 | -11 | -0.7 | -20 | -14 | 0.8 | -0.7 | -0.9 | -14 | |
| -20 | -5.7 | -31 | -13 | -14 | -4.0 | -7.7 | -8.9 | -4.3 | -5.7 | -5.9 | -25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.